Around the world clinics are working to improve outcomes for their patients. At CooperSurgical Fertility Solutions, we create lasting partnerships based on individual clinic’s challenges and customized solutions tailored to optimize the chances of success.
Our full range of solutions designed to optimize your results with specialized products covers every stage of the ART cycle. We also support and advance clinics by offering evidence-based training and solutions, designed to improve clinical performance and efficiency across the entire spectrum of ART. At CooperSurgical, we offer a unique approach within the fertility and genomics industry.
Jenna Miller is a board-certified genetic counselor with a Bachelor of Science degree in Genetics and Biotechnology from Brigham Young University and a Master of Science degree in Human Genetics from Sarah Lawrence College. Jenna began her career in 2014 at the biotech startup Recombine, where she provided genetic counseling and performed clinical diagnostics for expanded carrier screening. She has been CooperSurgical’s clinical science liaison since 2017. In this role, Jenna travels North America educating healthcare providers about genomics within ART. She regularly collaborates with patient organizations like Resolve and also leads CooperSurgical’s IVF outcome data collection efforts. Jenna is passionate about genomics education, fertility advocacy, and ethical approaches to genomic testing.
Mike earned his PhD from Baylor College of Medicine, where he focused on the intersection of progesterone and growth factor signaling and their role in endometrial receptivity. While finishing his work there, he was recruited by Mark Hughes of Genesis Genetics to open a Research and Development PGS laboratory in Houston, Texas. Mike quickly rose to prominence as a technical expert and was instrumental in the adoption and implementation of Next Generation. Shortly after being acquired by CooperSurgical, he was promoted to Director of Genomic Laboratories, overseeing multiple PGT-A labs. He next took on his current role leading research efforts in Genomics where his team develops state-of-the-art analytical methods for interrogating Reproductive Genetics.
George joined Cooper in October of 2020. George is the West Region Director for Fertility in the United States and has 17 years of experience in the Healthcare Industry.